Cargando…
Prospective observational study in patients with obstructive lung disease: NOVELTY design
Asthma and chronic obstructive pulmonary disease (COPD) have overlapping clinical features and share pathobiological mechanisms but are often considered distinct disorders. Prospective, observational studies across asthma, COPD and asthma–COPD overlap are limited. NOVELTY is a global, prospective ob...
Autores principales: | Reddel, Helen K., Gerhardsson de Verdier, Maria, Agustí, Alvar, Anderson, Gary, Beasley, Richard, Bel, Elisabeth H., Janson, Christer, Make, Barry, Martin, Richard J., Pavord, Ian, Price, David, Keen, Christina, Gardev, Asparuh, Rennard, Stephen, Sveréus, Alecka, Bansal, Aruna T., Brannman, Lance, Karlsson, Niklas, Nuevo, Javier, Nyberg, Fredrik, Young, Simon S., Vestbo, Jørgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355976/ https://www.ncbi.nlm.nih.gov/pubmed/30723727 http://dx.doi.org/10.1183/23120541.00036-2018 |
Ejemplares similares
-
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort
por: Reddel, Helen K., et al.
Publicado: (2021) -
Treatable traits in the NOVELTY study
por: Agustí, Alvar, et al.
Publicado: (2022) -
Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design
por: Vestbo, Jørgen, et al.
Publicado: (2020) -
Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
por: Karlsson, Niklas, et al.
Publicado: (2021) -
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
por: Chen, Wenjia, et al.
Publicado: (2023)